FDA Drugs (New Approvals & NDA)Original article
SCA Pharmaceuticals, LLC - 724202 - 09/14/2026
RegulatoryNegative
AI Analysis
Summary
SCA Pharmaceuticals, LLC (FDA Establishment #724202) received a regulatory action related to CGMP violations and adulterated finished pharmaceuticals. This indicates a manufacturing or quality compliance issue identified by the FDA.
Outcome Details
CGMP/Finished Pharmaceuticals/Adulterated
Importance:6/10
Sentiment:
-0.80
FDACGMPManufacturingAdulterationComplianceRegulatory Action
Read the original article
Published by FDA Drugs (New Approvals & NDA) on October 13, 2026 1:20 PM